ONCOQUEST PHARMA USA, INC — Form D
ONCOQUEST PHARMA USA, INC of MIRYANG SI, GYEONGSANGNAMDO, M5, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-13. The offering totals $510K, of which $510K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-01-13
- Form: D
- Accession: 0001213900-21-001774
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $510K
- Amount sold: $510K
- Investors: 1
- Date of first sale: 2020-12-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-386083
Issuer
- Name: ONCOQUEST PHARMA USA, INC
- CIK: 0001839861
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 670-21, SANNAE-RO, SANNAE-MYEON, MIRYANG SI, GYEONGSANGNAMDO, M5, 50414
- Phone: 82-55-352-4860
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Ragupathy Madiyalakan | Director | Edmonton, A0 |
| Ragupathy Madiyalakan | Executive Officer | Edmonton, A0 |
| Alex Jung | Director | Miryang Si, Gyeongsangnamdo, M5 |
| Alex Jung | Executive Officer | Miryang Si, Gyeongsangnamdo, M5 |
| Lyn Lim | Director | Miryang Si, Gyeongsangnamdo, M5 |
| Karthik Radhakrishnan | Director | Wilmington, DE |
| Karthik Radhakrishnan | Executive Officer | Wilmington, DE |
Other filings by this issuer (1)
More